 | Steven L. Jones (M.D.) - 2001 - 660 páginas
...including liver disease). f. Decreased euglobul in clot lysis BIBLIOGRAPHY Brandt JT, McLendon WW, eds. College of American Pathologists Conference XXXI on Laboratory Monitoring of Anticoagulant Therapy. Arch Pathol Lab Med 1998;122:765-S16. Miller JL. Blood coagulation and fibrinolysis. In: Henry JB.... | |
 | 2002 - 598 páginas
...Laboratory Monitoring of Anticoagulant Therapy. 1997. Are Pathol Lab Med.; 122: 768-781, 1998. 14. Laposata M, Green D, van Cott EM. Barrowcliffe TW, Goodnight SH, Sosolik Re. College of American Pathologists Conference XXXI on Laboratory Monitoring of Anticoagulant Therapy.... | |
 | Rodger L. Bick - 2002 - 472 páginas
...Conference on Antithrombotic Therapy. Chest 2001;! 19(suppl):l. 80. Laposata M, Green D, Van Cott EM, et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy. Arch Pathol Lab Med 1998:122:799. 8 1 . Fidlar E, Jaques LB. The effect of commercial heparin on the... | |
 | Antonio Raviele - 2003 - 958 páginas
...fibrillation. Am J Cardiol 88:1214-1216 16 Fairweather RB, Ansell J, Van den Besselaar AM et al (1998) College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy. Laboratory monitoring of oral anticoagulant therapy. Arch Pathol Lab Med 122:768-781 17. Pengo V, Biasiolo... | |
 | Theodore Warkentin, Andreas Greinacher - 2003 - 660 páginas
...heparin-induced thrombocytopenia type II undergoing cardiovascular surgery. J Clin Anesth 2000: l2:324 327. Laposata M. Green D. Van Cott EM. Barrowcliffe TW....Sosolik RC. College of American Pathologists Conference Therapy. The clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin... | |
 | Hari G. Garg, Robert J. Linhardt, Charles A. Hales - 2011 - 792 páginas
...Laboratory monitoring of unfractionated heparin therapy. Arch Pathol Lab Med 1998; 122:782-798. 25. Laposata M, Green D, Van Cott EM, Barrowcliffe TW,...monitoring of anticoagulant therapy. The clinical use of laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds,... | |
 | Rodger L. Bick, Eugene P. Frenkel, William F. Baker, Ravi Sarode - 2006 - 589 páginas
...monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy. Arch Path. Lab. Med., 122: 799, 1998. 11 Douiketis, IJD, Johnson, JA and Turpie, AG Low molecular weight... | |
 | John T. Daugirdas, Peter Gerard Blake, Todd S. Ing - 2007 - 806 páginas
...lipase stores and retards triglyceride clearing. Nephrol Dial Transplant 2005;20: 1172. Olson JD, et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy. Arch Pathol Lab Med 1998;122(9):782-798. Ouseph... | |
 | Theodore E. Warkentin, Andreas Greinacher - 2007 - 114 páginas
...heparin-induced thrombocytopenia type II undergoing cardiovascular surgery. J Clin Anesth 12:324-327, 2000. Laposata M, Green D, Van Cott EM, Barrowcliffe TW,...Sosolik RC. College of American Pathologists Conference Therapy. The clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin... | |
| |
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy. 